Axogen (AXGN) Share-based Compensation (2010 - 2026)
Axogen's (AXGN) quarterly Share-based Compensation came in at $8.8 million in Q1 2026, down 47.17% quarter-over-quarter from $16.6 million in Q4 2025.
Axogen (AXGN) Share-based Compensation (2010 - 2026) Analysis & Trends
Axogen's Share-based Compensation history runs 17 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- On a quarterly basis, Share-based Compensation changed N/A year-over-year to $8.8 million in Q1 2026; TTM through Mar 2026 was $38.9 million, a 224.42% increase from a year earlier, with the FY2025 full-year figure at $30.1 million, up 89.31% from the prior year.
- Share-based Compensation fell to $8.8 million in Q1 2026 per AXGN's latest filing, from $16.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $16.6 million in Q4 2025 and bottomed at $1.3 million in Q4 2023.
- The 5-year median for Share-based Compensation is $4.5 million (2022), against an average of $5.3 million.
- Across the five-year window, Share-based Compensation plunged 68.05% in 2023 and jumped 440.02% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $4.2 million in 2022, then plunged by 68.05% to $1.3 million in 2023, then jumped by 131.8% to $3.1 million in 2024, then soared by 440.02% to $16.6 million in 2025, then sank by 47.17% to $8.8 million in 2026.
- Per Business Quant, the three latest AXGN Share-based Compensation figures stand at $8.8 million (Q1 2026), $16.6 million (Q4 2025), and $5.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 8.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.78 Mn |
| Mar 31, 2026 | 8.78 Mn |
| Dec 31, 2025 | 16.61 Mn |
| Dec 31, 2025 | 16.61 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Jun 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 8.08 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Sep 30, 2023 | 4.75 Mn |